When we examined PBMC responses to the newly identified HIPs, we found that each individual with T1D has a CD4+ T cell response to a unique set of HIPs detected using the CFSE-based proliferation assay (35). The gene discussed is CD4; the disease is type 1 diabetes mellitus.